Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

[Urine cytology and new markers. Are there any advantages in terms of cost-effectiveness?].

Campodonico F.

Urologia. 2013;80 Suppl 21:7-10. doi: 10.5301/RU.2013.10856. Epub 2013 Mar 22. Italian.

PMID:
23559136
2.

Bladder tumor markers: a review of the literature.

Volpe A, Racioppi M, D'Agostino D, Cappa E, Gardi M, Totaro A, Pinto F, Sacco E, Marangi F, Palermo G, Bassi PF.

Int J Biol Markers. 2008 Oct-Dec;23(4):249-61. Review.

PMID:
19199274
3.

[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].

Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ.

Arch Esp Urol. 2002 Jan-Feb;55(1):41-9. Spanish.

PMID:
11957750
4.

Cost-effectiveness of fluorescence in situ hybridization in patients with atypical cytology for the detection of urothelial carcinoma.

Gayed BA, Seideman C, Lotan Y.

J Urol. 2013 Oct;190(4):1181-6. doi: 10.1016/j.juro.2013.03.117. Epub 2013 Apr 9.

PMID:
23583531
5.

Urine markers for bladder cancer surveillance: a systematic review.

van Rhijn BW, van der Poel HG, van der Kwast TH.

Eur Urol. 2005 Jun;47(6):736-48. Epub 2005 Mar 23. Review.

PMID:
15925067
6.

Urine cytology. It is still the gold standard for screening?

Brown FM.

Urol Clin North Am. 2000 Feb;27(1):25-37. Review.

PMID:
10696242
7.

The health economics of bladder cancer: a comprehensive review of the published literature.

Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R.

Pharmacoeconomics. 2003;21(18):1315-30. Review.

PMID:
14750899
8.

[Value of urinary markers in the diagnosis and follow-up of urothelial bladder tumours].

Campos-Fernandes JL, Descotes F, André J, Perrin P, Devonec M, Ruffion A.

Prog Urol. 2007 Feb;17(1):23-34. Review. French.

PMID:
17373233
9.

Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.

Pfister C, Chautard D, Devonec M, Perrin P, Chopin D, Rischmann P, Bouchot O, Beurton D, Coulange C, Rambeaud JJ.

J Urol. 2003 Mar;169(3):921-4.

PMID:
12576813
10.

The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.

Mian C, Lodde M, Comploj E, Palermo S, Mian M, Maier K, Pycha A.

Anticancer Res. 2005 Sep-Oct;25(5):3641-4.

11.

Urine markers for detection and surveillance of non-muscle-invasive bladder cancer.

Tilki D, Burger M, Dalbagni G, Grossman HB, Hakenberg OW, Palou J, Reich O, Rouprêt M, Shariat SF, Zlotta AR.

Eur Urol. 2011 Sep;60(3):484-92. doi: 10.1016/j.eururo.2011.05.053. Epub 2011 Jun 12. Review.

PMID:
21684071
12.
13.
14.

Diagnosis of urothelial carcinoma from urine.

Têtu B.

Mod Pathol. 2009 Jun;22 Suppl 2:S53-9. doi: 10.1038/modpathol.2008.193. Review.

15.

Economic impact of tumor markers in bladder cancer surveillance.

Hong YM, Loughlin KR.

Urology. 2008 Jan;71(1):131-5. doi: 10.1016/j.urology.2007.08.014. Review.

PMID:
18242381
16.

[Urinary cytology in cases of bladder cancer: a critical evaluation].

Rathert P.

Urologe A. 2003 Jul;42(7):908-11. Epub 2003 Mar 26. Review. German.

PMID:
12898033
17.

Proteomic assays for the detection of urothelial cancer.

Gaston KE, Grossman HB.

Methods Mol Biol. 2010;641:303-23. doi: 10.1007/978-1-60761-711-2_17. Review.

PMID:
20407954
18.

NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.

Zippe C, Pandrangi L, Potts JM, Kursh E, Novick A, Agarwal A.

Anticancer Res. 1999 Jul-Aug;19(4A):2621-3.

PMID:
10470205
19.

Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer.

Sánchez-Carbayo M, Urrutia M, González de Buitrago JM, Navajo JA.

Clin Cancer Res. 2000 Sep;6(9):3585-94.

20.

Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer.

Toma MI, Friedrich MG, Hautmann SH, Jäkel KT, Erbersdobler A, Hellstern A, Huland H.

World J Urol. 2004 Jun;22(2):145-9. Epub 2004 Feb 27.

PMID:
14991320

Supplemental Content

Support Center